Abbvie starts Phase III trial of lung cancer drug veliparib
US-based biopharmaceutical firm AbbVie has started a global Phase III clinical trial of an investigational oral poly (adenosine diphosphate -ribose) ...
US-based biopharmaceutical firm AbbVie has started a global Phase III clinical trial of an investigational oral poly (adenosine diphosphate -ribose) ...
Pleasanton, CA, USA, 21 February 2014 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today a licensing agreement with Sysmex ...
As concerns about bacterial resistance to antibiotics grow, researchers are racing to find new kinds of drugs to replace ones ...
Scientists at The Scripps Research Institute (TSRI) have demonstrated the power of a new drug discovery technique, which allows them ...
GlaxoSmithKline plc announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for Tafinlar® (dabrafenib) for ...
Some vegetable oils that claim to be healthy may actually increase the risk of heart disease, and Health Canada should ...
A collaboration among researchers in Israel and the United States has resulted in the discovery of a new pathway that ...
The stop and start of blood flow to the heart during and after a heart attack causes severe damage to ...
A new method for creating stem cells for the human liver and pancreas, which could enable both cell types to ...
University of Miami Miller School of Medicine researchers played a key role in the largest international Alzheimer's disease genetics collaboration ...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.